| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/06/2002 | WO2002068651A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068649A2 Proteins and nucleic acids encoding same |
| 09/06/2002 | WO2002068648A2 Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof |
| 09/06/2002 | WO2002068647A2 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | WO2002068646A2 Mammalian cytokines; receptors; related reagents and methods |
| 09/06/2002 | WO2002068645A2 Compositions and methods relating to breast specific genes and proteins |
| 09/06/2002 | WO2002068644A1 Promoter of s-adenosyl-l-methionine: jasmonic acid carboxyl methyl transferase gene and method for producing target protein in plants using the same |
| 09/06/2002 | WO2002068642A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 09/06/2002 | WO2002068641A1 THE INFLAMMATORY INHIBITION FACTOR Fwa116 |
| 09/06/2002 | WO2002068640A1 CELL PROLIFERATION FACTOR Fwa267 |
| 09/06/2002 | WO2002068639A1 CELL PROLIFERATION FACTOR Fwap10576 |
| 09/06/2002 | WO2002068638A1 83 human secreted proteins |
| 09/06/2002 | WO2002068637A2 Nucleic acid-based treatment of diseases or conditions related to west nile virus infection |
| 09/06/2002 | WO2002068636A1 Methods and agents for modifying human angiogenesis |
| 09/06/2002 | WO2002068633A2 Compositions and methods relating to lung specific genes and proteins |
| 09/06/2002 | WO2002068630A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | WO2002068628A1 70 human secreted proteins |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002068626A2 Novel human ion channel-related proteins and polynucleotides encoding the same |
| 09/06/2002 | WO2002068621A2 Rax-related protein |
| 09/06/2002 | WO2002068618A1 Methods for monitoring protease inhibitor antiretroviral therapy |
| 09/06/2002 | WO2002068615A2 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives |
| 09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | WO2002068610A2 Compositions and methods for affecting virulence determinants in bacteria |
| 09/06/2002 | WO2002068608A2 Sulfated ccr5 peptides for hiv-1 infection |
| 09/06/2002 | WO2002068607A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 09/06/2002 | WO2002068606A2 Methods for the identification of herbicides and the modulation of plant growth |
| 09/06/2002 | WO2002068605A2 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | WO2002068604A2 Polynucleotide encoding two novel human potassium channel beta-subunits, k+betam4 and k+betam5 |
| 09/06/2002 | WO2002068602A2 Methods for modulating g2a receptor activity |
| 09/06/2002 | WO2002068601A2 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 09/06/2002 | WO2002068600A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | WO2002068596A2 Mammalian cytokines; related reagents |
| 09/06/2002 | WO2002068594A2 Opiate receptors |
| 09/06/2002 | WO2002068593A2 Chemosensory gene family encoding gustatory and olfactory receptors and uses thereof |
| 09/06/2002 | WO2002068591A2 G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof |
| 09/06/2002 | WO2002068588A2 Cytokine receptor common gamma chain like |
| 09/06/2002 | WO2002068587A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3 |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
| 09/06/2002 | WO2002068474A1 Vaccine against cancer diseases that are associated with the her-2/neu oncogene |
| 09/06/2002 | WO2002068473A1 Biosensor for detecting chemical agents |
| 09/06/2002 | WO2002068472A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | WO2002068471A2 Nucleic acid molecules and polypeptides for a human cation channel polypeptide |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068469A2 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | WO2002068468A2 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 09/06/2002 | WO2002068467A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | WO2002068466A2 Hypoxia-regulated genes |
| 09/06/2002 | WO2002068465A2 Novel p53-inducible protein |
| 09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 09/06/2002 | WO2002068462A2 Internal standard for electrophoretic and chromatographic separation processes |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068460A1 Peptide tag for monitoring and purification of proteins |
| 09/06/2002 | WO2002068459A2 Non aggregating fluorescent proteins and methods for using the same |
| 09/06/2002 | WO2002068457A2 Antiangiogenic peptides derived from endostatin |
| 09/06/2002 | WO2002068455A2 Efficient recovery of correctly refolded proteins |
| 09/06/2002 | WO2002068451A2 Sperm protein 17 for the diagnosis and treatment of cancer |
| 09/06/2002 | WO2002068447A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 09/06/2002 | WO2002067996A2 Beta-endorphin/crf gene therapy for locally combating pain |
| 09/06/2002 | WO2002067982A2 Mycobacterial vaccines |
| 09/06/2002 | WO2002067971A2 Use of endostatin in the treatment of ocular neovascularization |
| 09/06/2002 | WO2002067968A2 14-3-3 binding molecules as sensitizers for anticancer therapies |
| 09/06/2002 | WO2002067959A1 Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and prepairing process thereof |
| 09/06/2002 | WO2002067868A2 Methods for the treatment of metabolic disorders, including obesity and diabetes |
| 09/06/2002 | WO2002067859A2 Ascorbic acid analogs for metalloradiopharmaceuticals |
| 09/06/2002 | WO2002067858A2 Novel treatment of neurodegenerative diseases by altering levels of trkb isoforms and/or trkc isoforms |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067670A1 Drosophila strain carrying bradeion gene(s) transferred thereinto |
| 09/06/2002 | WO2002067668A1 Schizophrenia-like mental disease model animal, method of constructing the same and use thereof |
| 09/06/2002 | WO2002050262A3 Mutant mycobacteria for use in therapy |
| 09/06/2002 | WO2002048182A3 Interferon-alpha induced gene |
| 09/06/2002 | WO2002047712A3 Peptide yy and peptide yy agonists for treatment of metabolic disorders |
| 09/06/2002 | WO2002046415A9 Polynucleotide and polypeptide sequences of putative transporters and ion channells |
| 09/06/2002 | WO2002046216A3 Human sprouty-4 polypeptide |
| 09/06/2002 | WO2002044376A8 Modulation of gene expression using insulator binding proteins |
| 09/06/2002 | WO2002044332A9 Prostate polynucleotides and uses |
| 09/06/2002 | WO2002042326A8 A method of expression and agents identified thereby |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002036792A3 Dna expression vectors |
| 09/06/2002 | WO2002036771A3 Imaging, diagnosis and treatment of disease |
| 09/06/2002 | WO2002036632A8 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides |
| 09/06/2002 | WO2002036609A3 Haplotypes of the chrm4 gene |
| 09/06/2002 | WO2002034923A3 Monocotyledon plant cells and plants which synthesise modified starch |
| 09/06/2002 | WO2002032931A3 Haplotypes of the fos gene |
| 09/06/2002 | WO2002028360A3 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 09/06/2002 | WO2002024149A3 Immunogen comprising ligand bound hiv envelpe protein |
| 09/06/2002 | WO2002018421A3 Human and mouse e2-protein, nucleic acids coding therefor and uses thereof |
| 09/06/2002 | WO2002010217A3 Endothelial cell expression patterns |
| 09/06/2002 | WO2002008449A3 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/06/2002 | WO2002002629A3 Grf2-binding proteins and applications thereof |
| 09/06/2002 | WO2001098363A3 Peptides for use in the immunotherapy of renal cell carcinoma |
| 09/06/2002 | WO2001098334A3 Streptococcus antigens |
| 09/06/2002 | WO2001092565A3 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 09/06/2002 | WO2001092523A3 Human polynucleotides and polypeptides encoded thereby |
| 09/06/2002 | WO2001085932A3 Immunogenic polypeptides encoded by mage minigenes and uses thereof |
| 09/06/2002 | WO2001085785A3 Ph domain-interacting protein |
| 09/06/2002 | WO2001085780A3 Nucleic acid binding polypeptides |